Trials / Unknown
UnknownNCT06171971
Clinical and Therapeutic Impact of Large Genomic Studies at Diagnosis in Pediatric Solid Cancers
Evaluation of the Clinical and Therapeutic Impact of Large Genomic Studies at Diagnosis in Pediatric Solid Cancers
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 230 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 1 Year – 22 Years
- Healthy volunteers
- —
Summary
Pediatric solid tumors with an unfavorable prognosis remain a public health issue due to their morbidity and mortality and their rapidly evolving profile. They are defined by an expected overall survival of \< 30%. Progress has been made in genomic medicine with existing recommendations for the adult population, with the objective of personalized medicine. Recommendations for the pediatric population are still under consideration
Conditions
Timeline
- Start date
- 2022-06-20
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2023-12-15
- Last updated
- 2023-12-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06171971. Inclusion in this directory is not an endorsement.